Newsroom

Sorted by: Latest

-

Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure

OSAKA, Japan--(BUSINESS WIRE)--Shionogi Announces FDA Approval of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure...
-

Brera Holdings PLC (NASDAQ: SLMT) (d/b/a Solmate Infrastructure) Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearing Cancelled

DUBLIN--(BUSINESS WIRE)--Brera Holdings PLC (Nasdaq: SLMT) (the “Company” or “Solmate Infrastructure”) today announced that it has received written notification from the Nasdaq Hearings Department confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1.00 per share (the “Minimum Bid Price Requirement”). As a result of the Company’s compliance with the Minimum Bid Price Requirement and...
-

Hilton Launches Undergraduate by Hilton, Accelerating Lifestyle Portfolio Growth

MCLEAN, Va.--(BUSINESS WIRE)--Hilton Launches Undergraduate by Hilton, Accelerating Lifestyle Portfolio Growth...
-

Qlik Survey: U.S. Workers Plan to Watch the World Cup on the Clock and Use AI to Catch Up

PHILADELPHIA--(BUSINESS WIRE)--New Qlik survey suggests the 2026 FIFA World Cup could become one of the first large-scale workplace stress tests of AI productivity in real time....
-

StubHub Named Official Open Distribution Partner of Danny Wimmer Presents

NEW YORK--(BUSINESS WIRE)--StubHub, the world's leading ticket marketplace, and Danny Wimmer Presents (DWP), one of the country's leading independent producers of destination music festivals and live events, today announced a partnership naming StubHub the Official Open Distribution Partner across DWP's U.S. festival portfolio. The agreement marks StubHub's largest festival partnership to date. Through the partnership, StubHub will support Danny Wimmer Presents festivals including Welcome To Ro...
-

Everus Announces Promotions of Behring, Hendricks

BISMARCK, N.D.--(BUSINESS WIRE)--Everus Construction Group (NYSE: ECG) announced today that Vice President of Technology Jason A. Behring has been promoted to vice president and chief information officer, and Vice President of Human Resources Britney A. Hendricks has been promoted to vice president and chief human resources officer. “These well-deserved promotions, which were approved by Everus’ board of directors, reflect the significant successful efforts that both Britney and Jason have led...
-

Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced interim analysis findings from the first 50 completed subjects enrolled in its ongoing randomized, double-blind, vehicle-controlled Phase 2 clinical trial evaluating GX-03 in adults with moderate-to-severe atopic dermatitis. The interim review was conducted under the study’s established i...
-

OSI Systems Receives $19 Million Order to Support Deployment of Non-Intrusive Inspection Solutions

HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Security division has received an order valued at approximately $19 million in North America to support the deployment of the Company’s non-intrusive inspection (NII) systems at cargo and vehicle inspection checkpoints, including civil works and systems integration. OSI Systems’ President and CEO, Ajay Mehra, commented, “This award reflects our continued partnership wit...
-

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the upcoming clinical availability of xH, a next-generation sequencing (NGS) test that uses a whole-genome sequencing (WGS) approach for the detection of actionable oncologic targets in peripheral blood and bone marrow samples from patients with hematologic malignancies. Tempus first announced the xH assay for research use only in January 2025....
-

Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows at the American Society for Mass Spectrometry (ASMS) Conference. Across research, biopharma and applied testing, scientists face increasingly complex samples, expanding data sets and greater pressure to deliver confident answers faster. Thermo Fisher helps solve that...